Publicaciones en colaboración con investigadores/as de Hospital de Cruces (23)

2023

  1. Analysis of germline variants in pediatric patients diagnosed with desmoid tumors and nuchal-type fibromas

    Translational Pediatrics, Vol. 12, Núm. 9, pp. 1715-1724

  2. Identification of germline cancer predisposition variants in pediatric sarcoma patients from somatic tumor testing

    Scientific Reports, Vol. 13, Núm. 1

2022

  1. Alveolar rhabdomyosarcoma with cannibalism and erythroid leukaemia-like morphology

    International Journal of Laboratory Hematology

  2. Clinical management of the acute complications of sickle cell anemia: 11 years of experience in a tertiary hospital

    Anales de Pediatria, Vol. 97, Núm. 1, pp. 4-11

2021

  1. Adrenocortical tumours in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendations

    Pediatric Blood and Cancer, Vol. 68, Núm. S4

  2. Children with progressive and relapsed pleuropulmonary blastoma: A European collaborative analysis

    Pediatric Blood and Cancer, Vol. 68, Núm. 12

  3. Consensus recommendations from the EXPeRT/PARTNER groups for the diagnosis and therapy of sex cord stromal tumors in children and adolescents

    Pediatric Blood and Cancer, Vol. 68, Núm. S4

  4. Cutaneous melanoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendations

    Pediatric Blood and Cancer, Vol. 68, Núm. S4

  5. Pleuropulmonary blastoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendations

    Pediatric Blood and Cancer, Vol. 68, Núm. S4

  6. Protein Tyrosine Phosphatases in Neuroblastoma: Emerging Roles as Biomarkers and Therapeutic Targets

    Frontiers in Cell and Developmental Biology, Vol. 9

2020

  1. Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications

    Journal of Hepatology, Vol. 73, Núm. 2, pp. 328-341

  2. Inequalities in diagnosis and registration of pediatric very rare tumors: a European study on pleuropulmonary blastoma

    European Journal of Pediatrics, Vol. 179, Núm. 5, pp. 749-756

  3. Mesothelioma in children and adolescents: the European Cooperative Study Group for Pediatric Rare Rumors (EXPeRT) contribution

    European Journal of Cancer, Vol. 140, pp. 63-70

  4. Optimised molecular genetic diagnostics of Fanconi anaemia by whole exome sequencing and functional studies

    Journal of Medical Genetics, Vol. 57, Núm. 4, pp. 258-268

2019

  1. CLAPO syndrome: Effective response to treatment with oral rapamycin

    Dermatologic Therapy, Vol. 32, Núm. 4

  2. Dosimetry-based high-activity therapy with 131I-metaiodobenzylguanidine (131I-mIBG) and topotecan for the treatment of high-risk refractory neuroblastoma

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 46, Núm. 7, pp. 1567-1575

  3. Dual-specificity phosphatases in neuroblastoma cell growth and differentiation

    International Journal of Molecular Sciences, Vol. 20, Núm. 5

  4. Multifocal lymphangioendotheliomatosis without thrombocytopenia or clinical signs of systemic bleeding

    Pediatric Dermatology, Vol. 36, Núm. 6, pp. 965-966

  5. Protein tyrosine phosphatase PTPN1 modulates cell growth and associates with poor outcome in human neuroblastoma

    Diagnostic Pathology, Vol. 14, Núm. 1

2018

  1. Paracentesis como tratamiento descompresivo abdominal en neuroblastoma MS con hepatomegalia masiva

    Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica, Vol. 31, Núm. 4, pp. 196-199